AI-Powered Pathology: Roche Acquires PathAI to Transform Diagnostics
Roche's acquisition of PathAI signals a major push towards AI-driven diagnostics in pathology.
Roche's acquisition of PathAI signals a major push towards AI-driven diagnostics in pathology.
The FDA introduces one-day inspectional assessments to enhance its oversight of the medical device industry.